Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2463838017 | Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
2469029013 | Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
2469508010 | Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | Erythromycin-containing product | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | Sulfafurazole-containing product | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Erythromycin | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Sulfisoxazole | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | Erythromycin ethyl succinate and sulfafurazole acetyl product | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Sulfisoxazole acetyl | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Erythromycin ethylsuccinate | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has manufactured dose form | Oral suspension | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | Sulfafurazole-containing product in oral dose form | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set